Label: SENNA LIQUID syrup
- NDC Code(s): 84447-120-01
- Packager: Belleview Biosciences
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated May 23, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredient (per 5 mL)
- Purpose
- Uses
- Ask a doctor before use if you have
- Stop use and ask a doctor if
- If pregnant or breast-feeding,
- KEEP OUT OF REACH OF CHILDREN
- OVERDOSAGE
-
Directions
- shake well before use
- do not exceed recommended dose
Age Starting Dose MMaximum Dose adults and children
12 years of age and over10 mL to 15 mL once a day preferably at bedtime;
increase as needed or
as recommended by a doctor15 mL in the morning and 15 mL at bedtime children under 12 years of age ask a doctor ask a doctor - Other information
- Inactive ingredients
- Questions or comments?
- SPL UNCLASSIFIED SECTION
- Do not use
- BULK SHIPMENT: For institutional or repackaging use only.
-
INGREDIENTS AND APPEARANCE
SENNA LIQUID
senna liquid syrupProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:84447-120 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES 8.8 mg in 5 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) SORBITOL (UNII: 506T60A25R) METHYLPARABEN (UNII: A2I8C7HI9T) AMMONIUM GLYCYRRHIZATE (UNII: 3VRD35U26C) POTASSIUM CITRATE (UNII: EE90ONI6FF) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) PROPYLPARABEN (UNII: Z8IX2SC1OH) CITRIC ACID ACETATE (UNII: DSO12WL7AU) SUCRALOSE (UNII: 96K6UQ3ZD4) Product Characteristics Color brown (Dark Brown) Score Shape Size Flavor CHERRY Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:84447-120-01 200000 mL in 1 DRUM; Type 0: Not a Combination Product 05/01/2025 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M007 05/01/2025 Labeler - Belleview Biosciences (131968803)


